Eleszto Genetika is a world leader in the genetic modification of yeast and other microbial platforms for the production of high-value target molecules. We work diligently and efficiently with our partners to help identify and create novel and efficient metabolic pathways to unlock greater value.
Mentions in press and media 2
| Date | Title | Description |
| 23.01.2025 | Pictor Biotech Inc. (d.b.a. SOLARBIOTECH), GPC Bio, and Eleszto Genetika Announce Strategic Unification | NORTON, Va., LA ROCHELLE, France and BUDAPEST, Hungary, Jan. 23, 2025 /PRNewswire/ -- Today, SOLARBIOTECH, GPC Bio, and Eleszto Genetika proudly announced their acquisition and strategic unification under a single ownership. This consolidat... |
| 22.01.2025 | Pictor Biotech creates “vertically integrated synthetic biology and biomanufacturing powerhouse” | Pictor Biotech, which was created last fall by former Novozymes exec Peter Rosholm to acquire the assets of bankrupt biomanufacturing startups Solar Biotech, has made two new acquisitions. The firms—France-based biotech equipment maker GPC ... |